Skip to main content
All articles
ConditionCancers & Screening

Liver Cancer Surveillance

Ultrasound + AFP every 6 months for patients with cirrhosis or chronic hepatitis B catches liver cancer early — when curative treatment is possible. The single most important thing you can do for these conditions.

5 min readLast reviewed: 24/04/2026SGA Hepatology Panel

Category

Screening

Red flags

1

This article is educational and does not replace your doctor's advice. Seek urgent care for any red-flag symptoms.

What is it?

Hepatocellular carcinoma (HCC) almost always develops in patients with chronic liver disease — especially cirrhosis and chronic hepatitis B. When found small (<3 cm) on surveillance, cure rates are high. When found late, treatment is palliative. Surveillance is the single most important factor in survival.

How common is it?

HCC risk: ~3-5% per year in patients with cirrhosis. Lower in chronic hepatitis B without cirrhosis (~0.5%/year).

Why does it happen?

Years of liver inflammation lead to genetic damage and eventually cancer. Higher risk: cirrhosis from any cause, chronic hepatitis B (even without cirrhosis), MASH, alcohol, hemochromatosis, Asian/African ancestry, family history of HCC.

Symptoms

  • Surveillance is for ASYMPTOMATIC patients — the goal is to find HCC before symptoms
  • When symptoms appear, the cancer is usually advanced

Red flags — seek urgent medical care

  • Worsening cirrhosis (new ascites, jaundice, weight loss)

    Investigate for HCC and other causes.

How is it diagnosed?

Surveillance: liver ultrasound + AFP every 6 months. Suspicious lesion → triple-phase CT or MRI with contrast — these can diagnose HCC without biopsy in many cases. Biopsy if imaging uncertain.

Outlook — what to expect

Early HCC found on surveillance: 5-year survival often >70% with surgery, transplant, or ablation. Late HCC: median survival 6-12 months. Surveillance saves lives — adherence is the challenge.

Treatment

Habits & Lifestyle

Adherence to surveillance schedule is the critical task.

  • Get ultrasound + AFP every 6 months without fail.
  • Treat underlying liver disease aggressively (antivirals for HBV, weight loss for MASLD, abstinence from alcohol).
  • Stop alcohol completely.
  • Vaccinate against hepatitis A and B.

Diet

Mediterranean diet plus underlying disease management.

  • Coffee 3-4 cups daily (unsweetened) is protective.

Medications

No specific drugs for screening — treat underlying liver disease.

  • Antivirals for chronic hepatitis B can reduce HCC risk.

Procedures & Surgery

Surveillance is the procedure.

  • Ultrasound + AFP every 6 months.
  • CT or MRI for suspicious lesions on ultrasound.
  • Treatment depends on stage at detection.

Questions to ask your doctor

Save this list or print it before your appointment — doctors appreciate prepared patients.

  1. When is my next ultrasound and AFP due?
  2. Am I in the high-risk group requiring surveillance?

Share this article

Medically reviewed by: SGA Hepatology Panel · Last reviewed 24/04/2026